Ovarian cancer antigen CA 125 levels in pelvic inflammatory disease and pregnancy

Circulating CA 125 levels were studied in patients with gynecologic cancer and pelvic inflammatory diseaseand in pregnant women. The CA 125 level was elevated (>;35 U/ml) in 69% (9/13) of patients with active ovarian cancerin 32% (7/22) of patients with active cervical or endometrial cancerin 24%...

Full description

Saved in:
Bibliographic Details
Published in:Cancer 1986-04, Vol.57 (7), p.1327-1329
Main Authors: Halila, Hannu, Stenman, Ulf‐Hǎkan, Seppälä, Markku
Format: Article
Language:English
Subjects:
Antigens, Neoplasm - analysis
Antigens, Tumor-Associated, Carbohydrate
Biological and medical sciences
Female
Female genital diseases
Gynecology. Andrology. Obstetrics
Humans
Medical sciences
Ovarian Neoplasms - immunology
Pelvic Inflammatory Disease - immunology
Pregnancy
Pregnancy, Ectopic - immunology
Tumors
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Circulating CA 125 levels were studied in patients with gynecologic cancer and pelvic inflammatory diseaseand in pregnant women. The CA 125 level was elevated (>;35 U/ml) in 69% (9/13) of patients with active ovarian cancerin 32% (7/22) of patients with active cervical or endometrial cancerin 24% (11/46) of pregnant womenand in 33% (10/30) of patients with acute pelvic inflammatory disease. Sixty‐three other patients with nonmalignant gynecologic disordersincluding 15 patients with ectopic pregnancyhad normal CA 125 levels. The occurrence of elevated CA 125 levels in patients with pelvic inflammatory disease can limit the use of the assay for diagnosis of cancer in young women. Gynecologic tumors may be associated with inflammatory reactions that may contribute to elevated CA 125 levels in some cancer patients.
ISSN:0008-543X
1097-0142
DOI:10.1002/1097-0142(19860401)57:7<1327::AID-CNCR2820570713>3.0.CO;2-Z